These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2436580)

  • 1. [A case of multiple myeloma responding very well to the combination of K18 with prednisolone].
    Ishioka C; Kanamaru R; Sato T; Konishi Y; Himori T; Mimata Y; Wakui A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1164-6. PubMed ID: 2436580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study of the antineoplastic activity of K18].
    Nakatani K; Miyagi N; Ezaki T; Sugisaki T; Sakamoto K; Watanabe A; Fujioka T; Shiratori T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1985-91. PubMed ID: 2423038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI), melphalan and prednisolone (HLBI-MP) in multiple myeloma].
    Hara M; Nakamura T; Fujii Y
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1338-41. PubMed ID: 3579331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of K18 (IgG-melphalan) for five cases of refractory multiple myeloma.
    Kanamaru R; Wakui A; Ishioka C; Okuno M; Konishi Y; Ishikawa A; Shibata H
    Sci Rep Res Inst Tohoku Univ Med; 1988 Dec; 35(1-4):35-40. PubMed ID: 3267125
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complete remission in multiple myeloma with natural interferon-alpha (HLBI) and melphalan/prednisolone intermittent therapy].
    Ito M; Nakagawa T; Imoto S; Isobe T; Nakao Y
    Rinsho Ketsueki; 1990 Jun; 31(6):847-52. PubMed ID: 2214176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical phase II study of K-18 in cancer of the digestive organs].
    Urushizaki I; Mogi Y; Kohgo Y; Onodera Y; Niitsu Y; Koyama R; Itaya H; Nakazawa O; Saijo N; Matsuda M
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):361-4. PubMed ID: 2449136
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of multiple myeloma. High-dose intermittent administration of cyclophosphamide and prednisolone--follow up study of 10 years period].
    Mizuno H; Ninomiya N; Ohta H; Tokoro K; Yasuma A; Ohnishi K; Ikeda Y
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2286-91. PubMed ID: 6639091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group.
    Imamura Y; Takagi T; Yawata Y; Nishinarita S; Kosaka M; Mikuni C; Takatsuki K; Sezaki T; Mori M; Tsuchiya J
    Int J Hematol; 1994 Feb; 59(2):113-23. PubMed ID: 8018904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effects of K-18 (IgG-melphalan) in hypoplastic leukemia: a case report].
    Takahashi I; Ohmoto E; Nakada H; Inagaki N; Nonaka K; Takeuchi M; Osada K; Tsurumi N; Uchida K; Yorimitsu S
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):159-62. PubMed ID: 2447835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Protracted pulse" chemotherapy for refractory myeloma: a preliminary report.
    Manoharan A
    Eur J Haematol; 1990 Nov; 45(5):274-5. PubMed ID: 2261956
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study on the chemotherapy of multiple myeloma. 1. Therapeutic effect of sequential combination therapy using melphalan, ifosfamide, and prednisolone].
    Sezaki T; Ishii H; Osada T; Adachi T; Takahashi I; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1982 Jun; 23(6):847-53. PubMed ID: 7176091
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of refractory multiple myeloma effectively treated with long-term oral etoposide].
    Tokiwa F; Utsunomiya A; Nakahara K; Shimotakahara S; Takeshita T; Makino T; Hanada S; Arima T
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):533-6. PubMed ID: 8452392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
    Takemori N; Kondo K; Kawamura T; Imai K; Sakurai H; Sato T
    Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment of secondary erythroleukemia with androgen].
    Ogata K; Futaki M; Inokuchi K; Gomi S; Ohki I; Kuwabara T; Dan KZ; Kuriya S; Nomura T; Shinohara T
    Rinsho Ketsueki; 1989 Jul; 30(7):1079-83. PubMed ID: 2810794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on chemotherapy for multiple myeloma. Part II: Prognostic factors of treatment with prednisolone and sequential melphalan and ifosfamide: MIP therapy].
    Sezaki T; Ishii H; Adachi T; Takahashi I; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1983 Apr; 24(4):433-9. PubMed ID: 6887543
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent therapy for refractory myeloma].
    Togawa A
    Rinsho Ketsueki; 1993 Apr; 34(4):450-4. PubMed ID: 8510332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ancillary measures in treatment of myeloma. Use of immune serum globulin, fluoride, or androgen.
    Schilling A; Finkel HE
    Arch Intern Med; 1975 Jan; 135(1):193-6. PubMed ID: 46143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on chemotherapy for multiple myeloma. Part III: The disappearance of M-protein in multiple myeloma].
    Adachi T; Hasegawa M; Asano K; Sezaki T; Ishii H; Takahashi I; Kimura I
    Rinsho Ketsueki; 1983 Apr; 24(4):440-7. PubMed ID: 6887544
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon.
    Murakami H; Ogawara H; Morita K; Saitoh T; Matsushima T; Tamura J; Sawamura M; Karasawa M; Miyawaki S; Schimano S; Satoh S; Tsuchiya J
    J Med; 1997; 28(5-6):311-8. PubMed ID: 9604789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the treatment of multiple myeloma].
    Wada M; Mizoguchi H
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.